These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 12032139)
21. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase. Andersson AK; Flodström M; Sandler S Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061 [TBL] [Abstract][Full Text] [Related]
22. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Darville MI; Eizirik DL Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830 [TBL] [Abstract][Full Text] [Related]
23. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259 [TBL] [Abstract][Full Text] [Related]
24. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo. Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496 [TBL] [Abstract][Full Text] [Related]
25. IL-1 produced and released endogenously within human islets inhibits beta cell function. Arnush M; Heitmeier MR; Scarim AL; Marino MH; Manning PT; Corbett JA J Clin Invest; 1998 Aug; 102(3):516-26. PubMed ID: 9691088 [TBL] [Abstract][Full Text] [Related]
26. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. Fasshauer M; Kralisch S; Klier M; Lossner U; Bluher M; Klein J; Paschke R J Endocrinol; 2004 Apr; 181(1):129-38. PubMed ID: 15072573 [TBL] [Abstract][Full Text] [Related]
27. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL. McKenzie MD; Dudek NL; Mariana L; Chong MM; Trapani JA; Kay TW; Thomas HE Int Immunol; 2006 Jun; 18(6):837-46. PubMed ID: 16574667 [TBL] [Abstract][Full Text] [Related]
28. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. Solomon M; Flodström-Tullberg M; Sarvetnick N Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051 [TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Corbett JA; Kwon G; Marino MH; Rodi CP; Sullivan PM; Turk J; McDaniel ML Am J Physiol; 1996 Jun; 270(6 Pt 1):C1581-7. PubMed ID: 8764139 [TBL] [Abstract][Full Text] [Related]
31. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. Cornish AL; Chong MM; Davey GM; Darwiche R; Nicola NA; Hilton DJ; Kay TW; Starr R; Alexander WS J Biol Chem; 2003 Jun; 278(25):22755-61. PubMed ID: 12665516 [TBL] [Abstract][Full Text] [Related]
32. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Han X; Sun Y; Scott S; Bleich D Diabetes; 2001 May; 50(5):1047-55. PubMed ID: 11334407 [TBL] [Abstract][Full Text] [Related]
33. Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets. Edén D; Siegbahn A; Mokhtari D Diabetologia; 2015 Nov; 58(11):2563-72. PubMed ID: 26271343 [TBL] [Abstract][Full Text] [Related]